Epigenetic silencing of neurofilament genes promotes an aggressive phenotype in breast cancer

References

• Baylin SB, Jones PA. A decade of exploring the cancer epigenome - biological and translational implications. Nat Rev Cancer 2011; 11:726-34; PMID:21941284; http://dx.doi.org/10.1038/nrc3130.
   PubMed Web of Science ®Google Scholar
• Schuebel KE, Chen W, Cope L, Glockner SC, Suzuki H, Yi JM, Chan TA, Van Neste L, Van Criekinge W, van den Bosch S, et al. Comparing the DNA hypermethylome with gene mutations in human colorectal cancer. PLoS Genet 2007; 3:1709-23; PMID:17892325; http://dx.doi.org/10.1371/journal.pgen.0030157.
   PubMed Web of Science ®Google Scholar
• Glockner SC, Dhir M, Yi JM, McGarvey KE, Van Neste L, Louwagie J, Chan TA, Kleeberger W, de Bruine AP, Smits KM, et al. Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer. Cancer Res 2009; 69:4691-9; PMID:19435926; http://dx.doi.org/10.1158/0008-5472.CAN-08-0142.
   PubMed Web of Science ®Google Scholar
• Zhang W, Glockner SC, Guo M, Machida EO, Wang DH, Easwaran H, Van Neste L, Herman JG, Schuebel KE, Watkins DN, et al. Epigenetic inactivation of the canonical Wnt antagonist SRY-box containing gene 17 in colorectal cancer. Cancer Res 2008; 68:2764-72; PMID:18413743; http://dx.doi.org/10.1158/0008-5472.CAN-07-6349.
   PubMed Web of Science ®Google Scholar
• Yi JM, Dhir M, Van Neste L, Downing SR, Jeschke J, Glockner SC, de Freitas Calmon M, Hooker CM, Funes JM, Boshoff C, et al. Genomic and epigenomic integration identifies a prognostic signature in colon cancer. Clin Cancer Res 2011; 17:1535-45; PMID:21278247; http://dx.doi.org/10.1158/1078-0432.CCR-10-2509.
   PubMed Web of Science ®Google Scholar
• Jeschke J, Van Neste L, Glockner SC, Dhir M, Calmon MF, Deregowski V, Van Criekinge W, Vlassenbroeck I, Koch A, Chan TA, et al. Biomarkers for detection and prognosis of breast cancer identified by a functional hypermethylome screen. Epigenet 2012; 7:701-9; PMID:22647880; http://dx.doi.org/10.4161/epi.20445.
   PubMed Web of Science ®Google Scholar
• Jeschke J, O'Hagan HM, Zhang W, Vatapalli R, Calmon MF, Danilova L, Nelkenbrecher C, Van Neste L, Bijsmans IT, Van Engeland M, et al. Frequent inactivation of cysteine dioxygenase type 1 contributes to survival of breast cancer cells and resistance to anthracyclines. Clin Cancer Res 2013; 19:3201-11; PMID:23630167; http://dx.doi.org/10.1158/1078-0432.CCR-12-3751.
   PubMed Web of Science ®Google Scholar
• Fang F, Turcan S, Rimner A, Kaufman A, Giri D, Morris LG, Shen R, Seshan V, Mo Q, Heguy A, et al. Breast cancer methylomes establish an epigenomic foundation for metastasis. Sci Translat Med 2011; 3:75ra25; PMID:21430268; http://dx.doi.org/10.1126/scitranslmed.3001875.
   PubMed Web of Science ®Google Scholar
• Fackler MJ, Umbricht CB, Williams D, Argani P, Cruz LA, Merino VF, Teo WW, Zhang Z, Huang P, Visvananthan K, et al. Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence. Cancer Res 2011; 71:6195-207; PMID:21825015; http://dx.doi.org/10.1158/0008-5472.CAN-11-1630.
   PubMed Web of Science ®Google Scholar
• Bediaga NG, Acha-Sagredo A, Guerra I, Viguri A, Albaina C, Ruiz Diaz I, Rezola R, Alberdi MJ, Dopazo J, Montaner D, et al. DNA methylation epigenotypes in breast cancer molecular subtypes. Breast Cancer Res 2010; 12:R77; PMID:20920229; http://dx.doi.org/10.1186/bcr2721.
   PubMed Web of Science ®Google Scholar
• Hill VK, Ricketts C, Bieche I, Vacher S, Gentle D, Lewis C, Maher ER, Latif F. Genome-wide DNA methylation profiling of CpG islands in breast cancer identifies novel genes associated with tumorigenicity. Cancer Res 2011; 71:2988-99; PMID:21363912; http://dx.doi.org/10.1158/0008-5472.CAN-10-4026.
   PubMed Web of Science ®Google Scholar
• Liem RK, Yen SH, Salomon GD, Shelanski ML. Intermediate filaments in nervous tissues. J Cell Biol 1978; 79:637-45; PMID:83322; http://dx.doi.org/10.1083/jcb.79.3.637.
   PubMed Web of Science ®Google Scholar
• Steinert PM, Roop DR. Molecular and cellular biology of intermediate filaments. Annu Rev Biochem 1988; 57:593-625; PMID:3052284; http://dx.doi.org/10.1146/annurev.bi.57.070188.003113.
   PubMed Web of Science ®Google Scholar
• Friede RL, Samorajski T. Axon caliber related to neurofilaments and microtubules in sciatic nerve fibers of rats and mice. Anat Rec 1970; 167:379-87; PMID:5454590; http://dx.doi.org/10.1002/ar.1091670402.
   PubMedGoogle Scholar
• Hoffman PN, Griffin JW, Price DL. Control of axonal caliber by neurofilament transport. J Cell Biol 1984; 99:705-14; PMID:6204997; http://dx.doi.org/10.1083/jcb.99.2.705.
   PubMed Web of Science ®Google Scholar
• Kudo LC, Parfenova L, Vi N, Lau K, Pomakian J, Valdmanis P, Rouleau GA, Vinters HV, Wiedau-Pazos M, Karsten SL. Integrative gene-tissue microarray-based approach for identification of human disease biomarkers: application to amyotrophic lateral sclerosis. Hum Mol Genet 2010; 19:3233-53; PMID:20530642; http://dx.doi.org/10.1093/hmg/ddq232.
   PubMed Web of Science ®Google Scholar
• Skvortsova V, Shadrina M, Slominsky P, Levitsky G, Kondratieva E, Zherebtsova A, Levitskaya N, Alekhin A, Serdyuk A, Limborska S. Analysis of heavy neurofilament subunit gene polymorphism in Russian patients with sporadic motor neuron disease (MND). Eur J Hum Genet 2004; 12:241-4; PMID:14722583; http://dx.doi.org/10.1038/sj.ejhg.5201144.
   PubMed Web of Science ®Google Scholar
• Mersiyanova IV, Perepelov AV, Polyakov AV, Sitnikov VF, Dadali EL, Oparin RB, Petrin AN, Evgrafov OV. A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. Am J Hum Genet 2000; 67:37-46; PMID:10841809; http://dx.doi.org/10.1086/302962.
   PubMed Web of Science ®Google Scholar
• Alholle A, Brini AT, Gharanei S, Vaiyapuri S, Arrigoni E, Dallol A, Gentle D, Kishida T, Hiruma T, Avigad S, et al. Functional epigenetic approach identifies frequently methylated genes in Ewing sarcoma. Epigenetics 2013; 8:1198-204; PMID:24005033; http://dx.doi.org/10.4161/epi.26266.
   PubMed Web of Science ®Google Scholar
• Huang Z, Zhuo Y, Shen Z, Wang Y, Wang L, Li H, Chen J, Chen W. The role of NEFL in cell growth and invasion in head and neck squamous cell carcinoma cell lines. J Oral Pathol Med 2013; 43(3):191-8.
   PubMed Web of Science ®Google Scholar
• Revill K, Wang T, Lachenmayer A, Kojima K, Harrington A, Li J, Hoshida Y, Llovet JM, Powers S. Genome-wide methylation analysis and epigenetic unmasking identify tumor suppressor genes in hepatocellular carcinoma. Gastroenterology 2013; 145:1424-35 e1-25; PMID:24012984; http://dx.doi.org/10.1053/j.gastro.2013.08.055.
   PubMed Web of Science ®Google Scholar
• Emi M, Fujiwara Y, Nakajima T, Tsuchiya E, Tsuda H, Hirohashi S, Maeda Y, Tsuruta K, Miyaki M, Nakamura Y. Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer. Cancer Res 1992; 52:5368-72; PMID:1356616.
   PubMed Web of Science ®Google Scholar
• Vogelstein B, Fearon ER, Kern SE, Hamilton SR, Preisinger AC, Nakamura Y, White R. Allelotype of colorectal carcinomas. Science 1989; 244:207-11; PMID:2565047; http://dx.doi.org/10.1126/science.2565047.
   PubMed Web of Science ®Google Scholar
• Yaremko ML, Kutza C, Lyzak J, Mick R, Recant WM, Westbrook CA. Loss of heterozygosity from the short arm of chromosome 8 is associated with invasive behavior in breast cancer. Genes Chromosomes Cancer 1996; 16:189-95; http://dx.doi.org/10.1002/(SICI)1098-2264(199607)16:3%3c189::AID-GCC6%3e3.0.CO;2-V.
   PubMed Web of Science ®Google Scholar
• Kim MS, Chang X, LeBron C, Nagpal JK, Lee J, Huang Y, Yamashita K, Trink B, Ratovitski EA, Sidransky D. Neurofilament heavy polypeptide regulates the Akt-β-catenin pathway in human esophageal squamous cell carcinoma. PloS One 2010; 5:e9003; PMID:20140245; http://dx.doi.org/10.1371/journal.pone.0009003.
   PubMedGoogle Scholar
• Dubrowinskaja N, Gebauer K, Peters I, Hennenlotter J, Abbas M, Scherer R, Tezval H, Merseburger AS, Stenzl A, Grunwald V, et al. Neurofilament Heavy polypeptide CpG island methylation associates with prognosis of renal cell carcinoma and prediction of antivascular endothelial growth factor therapy response. Cancer Med 2014; 3(2):300-9; PMID:24464810.
   PubMed Web of Science ®Google Scholar
• Petzold A. Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss. J Neurol Sci 2005; 233:183-98; PMID:15896809; http://dx.doi.org/10.1016/j.jns.2005.03.015.
   PubMed Web of Science ®Google Scholar
• Mikkelsen TS, Ku M, Jaffe DB, Issac B, Lieberman E, Giannoukos G, Alvarez P, Brockman W, Kim TK, Koche RP, et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 2007; 448:553-60; PMID:17603471; http://dx.doi.org/10.1038/nature06008.
   PubMed Web of Science ®Google Scholar
• Gal-Yam EN, Egger G, Iniguez L, Holster H, Einarsson S, Zhang X, Lin JC, Liang G, Jones PA, Tanay A. Frequent switching of Polycomb repressive marks and DNA hypermethylation in the PC3 prostate cancer cell line. Proc Natl Acad Sci U S A 2008; 105:12979-84; PMID:18753622; http://dx.doi.org/10.1073/pnas.0806437105.
   PubMed Web of Science ®Google Scholar
• Schlesinger Y, Straussman R, Keshet I, Farkash S, Hecht M, Zimmerman J, Eden E, Yakhini Z, Ben-Shushan E, Reubinoff BE, et al. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat Genet 2007; 39:232-6; PMID:17200670; http://dx.doi.org/10.1038/ng1950.
   PubMed Web of Science ®Google Scholar
• Bachman KE, Park BH, Rhee I, Rajagopalan H, Herman JG, Baylin SB, Kinzler KW, Vogelstein B. Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene. Cancer Cell 2003; 3:89-95; PMID:12559178; http://dx.doi.org/10.1016/S1535-6108(02)00234-9.
   PubMed Web of Science ®Google Scholar
• Ohm JE, McGarvey KM, Yu X, Cheng L, Schuebel KE, Cope L, Mohammad HP, Chen W, Daniel VC, Yu W, et al. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet 2007; 39:237-42; PMID:17211412; http://dx.doi.org/10.1038/ng1972.
   PubMed Web of Science ®Google Scholar
• Ohm JE, Baylin SB. Stem cell chromatin patterns: an instructive mechanism for DNA hypermethylation? Cell Cycle 2007; 6:1040-3; PMID:17457052; http://dx.doi.org/10.4161/cc.6.9.4210.
   PubMed Web of Science ®Google Scholar
• Easwaran H, Johnstone SE, Van Neste L, Ohm J, Mosbruger T, Wang Q, Aryee MJ, Joyce P, Ahuja N, Weisenberger D, et al. A DNA hypermethylation module for the stem/progenitor cell signature of cancer. Genome Res 2012; 22:837-49; PMID:22391556; http://dx.doi.org/10.1101/gr.131169.111.
   PubMed Web of Science ®Google Scholar
• Liang J, Slingerland JM. Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle 2003; 2:339-45; PMID:12851486; http://dx.doi.org/10.4161/cc.2.4.433.
   PubMed Web of Science ®Google Scholar
• Hayes MJ, Thomas D, Emmons A, Giordano TJ, Kleer CG. Genetic changes of Wnt pathway genes are common events in metaplastic carcinomas of the breast. Clin Cancer Res 2008; 14:4038-44; PMID:18593979; http://dx.doi.org/10.1158/1078-0432.CCR-07-4379.
   PubMed Web of Science ®Google Scholar
• Kizildag S, Zengel B, Vardar E, Sakizli M. β-catenin gene mutation in invasive ductal breast cancer. J BUON 2008; 13:533-6.
   PubMed Web of Science ®Google Scholar
• Li XQ, Li L, Xiao CH, Feng YM. NEFL mRNA expression level is a prognostic factor for early-stage breast cancer patients. PloS One 2012; 7:e31146; PMID:22319610; http://dx.doi.org/10.1371/journal.pone.0031146.
   PubMedGoogle Scholar
• Price ME, Cotton AM, Lam LL, Farre P, Emberly E, Brown CJ, Robinson WP, Kobor MS. Additional annotation enhances potential for biologically-relevant analysis of the Illumina Infinium HumanMethylation450 BeadChip array. Epigenetics Chromatin 2013; 6:4; PMID:23452981; http://dx.doi.org/10.1186/1756-8935-6-4.
   PubMed Web of Science ®Google Scholar
• Dedeurwaerder S, Defrance M, Calonne E, Denis H, Sotiriou C, Fuks F. Evaluation of the Infinium Methylation 450K technology. Epigenomics 2011; 3:771-84; http://dx.doi.org/10.2217/epi.11.105.
   PubMed Web of Science ®Google Scholar
• Dedeurwaerder S, Defrance M, Bizet M, Calonne E, Bontempi G, Fuks F. A comprehensive overview of Infinium HumanMethylation450 data processing. Brief Bioinform 2014; 15:929-41; PMID:23990268; http://dx.doi.org/10.1093/bib/bbt054.
   PubMed Web of Science ®Google Scholar
• Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1996; 93:9821-6; PMID:8790415; http://dx.doi.org/10.1073/pnas.93.18.9821.
   PubMed Web of Science ®Google Scholar
• Fahrner JA, Eguchi S, Herman JG, Baylin SB. Dependence of histone modifications and gene expression on DNA hypermethylation in cancer. Cancer Res 2002; 62:7213-8; PMID:12499261.
   PubMed Web of Science ®Google Scholar
• Clements EG, Mohammad HP, Leadem BR, Easwaran H, Cai Y, Van Neste L, Baylin SB. DNMT1 modulates gene expression without its catalytic activity partially through its interactions with histone-modifying enzymes. Nucleic Acids Res 2012; 40:4334-46; PMID:22278882; http://dx.doi.org/10.1093/nar/gks031.
   PubMed Web of Science ®Google Scholar
• Thijssen PE, Tobi EW, Balog J, Schouten SG, Kremer D, El Bouazzaoui F, Henneman P, Putter H, Slagboom PE, Heijmans BT, et al. Chromatin remodeling of human subtelomeres and TERRA promoters upon cellular senescence Commonalities and differences between chromosomes. Epigenetics 2013; 8:512-21; PMID:23644601; http://dx.doi.org/10.4161/epi.24450.
   PubMed Web of Science ®Google Scholar